Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study) a cross-sectional multicentre study in Spain - Search Results

guest :: login

Home > Search Results: Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study) a cross-sectional multicentre study in Spain

Search collections:

Sort by:	Display results:	Output format:

Results overview: Found 1 records in 0.08 seconds.
Articles, 1 records found

Articles	1 records found

8 p, 898.4 KB

Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain / Conget, Ignacio (Hospital Clínic i Provincial de Barcelona) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ortega Basagoiti, Rafael (GlaxoSmithKline) ; Detournay, Bruno (Cemka Eval)
Several glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1Ra) have been made recently available in Spain for type 2 diabetes mellitus (DM2) treatment. There are no published data on the clinical and sociodemographic profile of patients initiating treatment with GLP-1Ra in Spain. [...]
2016 - DOI (Digital Object Identifier)

10.1136/bmjopen-2015-010197
BMJ open, Vol. 6 Núm. 7 (July 2016) , p. e010197

2 documents

Detailed record -

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.